218 related articles for article (PubMed ID: 31412889)
1. Antiretroviral treatment, government policy and economy of HIV/AIDS in Brazil: is it time for HIV cure in the country?
Benzaken AS; Pereira GFM; Costa L; Tanuri A; Santos AF; Soares MA
AIDS Res Ther; 2019 Aug; 16(1):19. PubMed ID: 31412889
[TBL] [Abstract][Full Text] [Related]
2. Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.
Nunn AS; Fonseca EM; Bastos FI; Gruskin S; Salomon JA
PLoS Med; 2007 Nov; 4(11):e305. PubMed ID: 18001145
[TBL] [Abstract][Full Text] [Related]
3. The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children.
Waning B; Diedrichsen E; Jambert E; Bärnighausen T; Li Y; Pouw M; Moon S
BMC Pediatr; 2010 Oct; 10():74. PubMed ID: 20950492
[TBL] [Abstract][Full Text] [Related]
4. Asserting the primacy of health over patent rights: a comparative study of the processes that led to the use of compulsory licensing in Thailand and Brazil.
Rosenberg ST
Dev World Bioeth; 2014 Aug; 14(2):83-91. PubMed ID: 24750542
[TBL] [Abstract][Full Text] [Related]
5. Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?
Meiners C; Sagaon-Teyssier L; Hasenclever L; Moatti JP
PLoS One; 2011; 6(8):e23478. PubMed ID: 21858138
[TBL] [Abstract][Full Text] [Related]
6. Brazil's AIDS controversy: antiretroviral drugs, breaking patents, and compulsory licensing.
Marques UR; Guimarães VS; Sternberg C
Food Drug Law J; 2005; 60(3):471-7. PubMed ID: 16304752
[No Abstract] [Full Text] [Related]
7. The Brazilian experiment: HIV drugs for all.
Flaer PJ; Younis MZ
J Health Care Finance; 2009; 36(2):90-6. PubMed ID: 20499725
[TBL] [Abstract][Full Text] [Related]
8. What strategies to boost production of affordable fixed-dose anti-retroviral drug combinations for children in the developing world?
Dionisio D; Gass R; McDermott P; Racalbuto V; Madeo M; Braghieri G; Crowley S; Pinheiro Edos S; Graaff P; Vasan A; Eksaengsri A; Moller H; Khanna AK; Kraisintu K; Juneja S; Nicolaou S; Sengupta A; Esperti F; Messeri D
Curr HIV Res; 2007 Mar; 5(2):155-87. PubMed ID: 17346132
[TBL] [Abstract][Full Text] [Related]
9. Rationing antiretroviral therapy for HIV/AIDS in Africa: choices and consequences.
Rosen S; Sanne I; Collier A; Simon JL
PLoS Med; 2005 Nov; 2(11):e303. PubMed ID: 16159308
[TBL] [Abstract][Full Text] [Related]
10. Brazil and access to HIV/AIDS drugs: a question of human rights and public health.
Galvão J
Am J Public Health; 2005 Jul; 95(7):1110-6. PubMed ID: 15933238
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing global antiretroviral procurement prices.
Wirtz VJ; Forsythe S; Valencia-Mendoza A; Bautista-Arredondo S
BMC Public Health; 2009 Nov; 9 Suppl 1(Suppl 1):S6. PubMed ID: 19922690
[TBL] [Abstract][Full Text] [Related]
12. Brazil's fight against AIDS and its implications for global health governance.
Wogart JP; Calcagnotto G
Healthc Q; 2006; 9(1):76-89. PubMed ID: 16548439
[TBL] [Abstract][Full Text] [Related]
13. AIDS treatment in Brazil: impacts and challenges.
Nunn AS; da Fonseca EM; Bastos FI; Gruskin S
Health Aff (Millwood); 2009; 28(4):1103-13. PubMed ID: 19597210
[TBL] [Abstract][Full Text] [Related]
14. We are all people living with AIDS: myths and realities of AIDS in Brazil.
Daniel H
Int J Health Serv; 1991; 21(3):539-51. PubMed ID: 1917212
[TBL] [Abstract][Full Text] [Related]
15. [Sustainability of Brazilian policy for access to antiretroviral drugs].
Grangeiro A; Teixeira L; Bastos FI; Teixeira P
Rev Saude Publica; 2006 Apr; 40 Suppl():60-9. PubMed ID: 16729160
[TBL] [Abstract][Full Text] [Related]
16. Progress of the National Pediatric Free Antiretroviral Therapy program in China.
Zhao Y; Sun X; He Y; Tang Z; Peng G; Liu A; Qiao X; Li H; Chen Z; Dou Z; Ma Y; Liu Z; Zhang F
AIDS Care; 2010 Oct; 22(10):1182-8. PubMed ID: 20665285
[TBL] [Abstract][Full Text] [Related]
17. Drugs for all: the future of global AIDS treatment.
Biehl J
Med Anthropol; 2008; 27(2):99-105. PubMed ID: 18464125
[TBL] [Abstract][Full Text] [Related]
18. Barriers along the care cascade of HIV-infected men in a large urban center of Brazil.
Hoffmann M; MacCarthy S; Batson A; Crawford-Roberts A; Rasanathan J; Nunn A; Silva LA; Dourado I
AIDS Care; 2016; 28(1):57-62. PubMed ID: 26291264
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral manufacturers and the challenge of universal access to drugs through the Brazilian National STD/AIDS Program.
do Lago RF; Costa Ndo R
Cad Saude Publica; 2009 Oct; 25(10):2273-84. PubMed ID: 19851626
[TBL] [Abstract][Full Text] [Related]
20. Introduction: the realities of antiretroviral therapy rollout: overcoming challenges to successful programmatic implementation.
Ojikutu B
J Infect Dis; 2007 Dec; 196 Suppl 3():S445-8. PubMed ID: 18181692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
